http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#Head
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#assertion
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#provenance
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#pubinfo
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#assertion
http://purl.obolibrary.org/obo/DOID_0060329
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_0060329
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00834
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#association
http://www.w3.org/2000/01/rdf-schema#label
"Administration of Mifepristone tablets, 200mg and misoprostol for the termination of pregnancy (the ""treatment procedure"") is contraindicated in patients with any of the following conditions: - [ see Warnings and Precautions ( 5.4 - - - [ see Adverse Reactions ( 6.2 - - Use of Mifepristone tablets, 200mg and misoprostol for termination of intrauterine pregnancy is contraindicated in patients with an intrauterine device (""IUD"") in place (the IUD might interfere with pregnancy termination). If the IUD is removed, Mifepristone tablets, 200mg may be used. Confirmed/suspected ectopic pregnancy or undiagnosed adnexal mass ( 4 Chronic adrenal failure ( 4 Concurrent long-term corticosteroid therapy ( 4 History of allergy to mifepristone, misoprostol, or other prostaglandins ( 4 Hemorrhagic disorders or concurrent anticoagulant therapy ( 4 Inherited porphyria ( 4 Intrauterine device (IUD) in place ( 4"
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB00834
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#provenance
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#pubinfo
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#sig
http://purl.org/nanopub/x/hasSignature
MiJ2d8T4YM9Y5+vTXmHhiiKj9zjGrZxCttC/tM/FIaR+nL5pgqXz7ZTr4wQXbLa2ZSpXbXqZMiNGEpUu/ucjae/g4xS1Ay5Vn+HGhO/25vgnncizGdcUY3QYfFU+lhcUXPWSlPHc8MFRPrqdBSy871NgSRP1U+ALAA1DAeQR6FA=
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI
http://purl.org/dc/terms/created
2021-08-23T18:41:12.827+02:00
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY